Showing 701-710 of 856 results for "".
- SkinPen Precision Cleared for Neck Skin Treatmenthttps://modernaesthetics.com/news/skinpen-precision-cleared-for-neck-skin-treatment/2473081/SkinPen® Precision from Crown Aesthetics is now cleared for the treatment of wrinkles on the neck. The FDA clearance is based on results of a recent single-center clinical study, which demonstrated clinical improvement of dermal lines on the neck and high patient satisfaction at one and
- Solta Rolls Out Next Generation Clear + Brilliant Laserhttps://modernaesthetics.com/news/solta-rolls-out-next-generation-clear-brilliant-laser/2473069/Solta Medical is launching Clear + Brilliant Touch laser, the company’s next generation Clear + Brilliant laser. By seamlessly switching between two wavelengths with the Original and Perméa handpieces, physicians can now more easily deliver a
- And The Winner Is... Algeness Named Top Finalist in Terra2 Solution Skin Health Innovation Competitionhttps://modernaesthetics.com/news/and-the-winner-is-algeness-named-top-finalist-in-terra2-solution-skin-health-innovation-competition/2473067/Advanced Aesthetic Technologies, Inc. (AAT) and Algeness are finalists in the recent Terra2 Solutions Skin Health Innovation Competition. Algeness is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural and based on purified agarose with
- Pre-clinical Data Suggest Soliton's RAP Technology Can Help Liver Fibrosishttps://modernaesthetics.com/news/pre-clinical-data-suggest-solitons-rap-technology-can-help-liver-fibrosis/2473066/A pre-clinical study in animals demonstrates positive results for Soliton’s RAP device as a potential treatment for liver fibrosis. Validated laboratory and histological assessments in a mouse model demonstrated that Rapid Acoustic Pulse (RAP) therapy reduced the effects of induced liver fi
- Introducing the Cutaneous Procedures Adverse Events Reporting (CAPER) Systemhttps://modernaesthetics.com/news/introducing-the-cutaneous-procedures-adverse-events-reporting-caper-system/2473065/The American Society for Dermatologic Surgery Association (ASDSA) and the Northwestern University Department of Dermatology are launching the Cutaneous Procedures Adverse Events Reporting (CAPER) system. This voluntary reporting system gathers patients’ adverse events (AEs) encoun
- Industry Responds to COVID-19: Biopelle, Galderma US Aestheticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-biopelle-galderma-us-aesthetics/2473063/Biopelle One bright spot for many aesthetic practices during the COVID-19 pandemic has been persistent and perhaps increased demand for skincare. Biopelle has responded to support physicians who wish to dispense their products. “We offer a ski
- Soliton Receives Best New Technology Awardhttps://modernaesthetics.com/news/soliton-named-best-new-technology/2473062/Soliton's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA). The Soliton RAP device, which uses proprietary design acoustic shockwaves to mechanically disrupt targeted cellular structures in a completely
- ASDS Issues New Recommendations on Preventing and Treating Filler Complicationshttps://modernaesthetics.com/news/asds-issues-new-recommendations-on-preventing-and-treating-filler-complications/2473060/The American Society for Dermatologic Surgery (ASDS) Multispecialty Soft-tissue Fillers Guideline Task Force has
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- Business News: Dominion Aesthetic Technologies Closes $23.7 Million Series B Financinghttps://modernaesthetics.com/news/business-news-dominion-aesthetic-technologies-closes-237-million-series-b-financing/2473052/Dominion Aesthetic Technologies, developers of EON, closed Series B financing, raising a total of $23.7 million. The series B funding will accelerate the manufacturing and commercialization of EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasi